HC Wainwright Issues Pessimistic Forecast for United States Antimony (NYSE:UAMY) Stock Price

Key Points

• HC Wainwright cut its price target on United States Antimony from $9.25 to $6.50 but maintained a Buy rating; the revised target implies 121.77% upside from the prior close.
• Shares fell 6.1% and opened at $2.93, below their 50-day and 200-day moving averages. The company reported a quarterly loss of $0.06 per share on $10.13 million in revenue.
• Analyst opinion is mixed but averages to a Moderate Buy, with a consensus price target of $8.75. Company insiders bought 62,700 shares worth about $298,600 over the last quarter.

United States Antimony (NYSE:UAMY - Get Free Report) had its target price reduced by research analysts at HC Wainwright from $9.25 to $6.50 in a research report issued on Friday, Benzinga reports. The brokerage presently has a "buy" rating on the stock. HC Wainwright's price target points to a potential upside of 121.77% from the stock's previous close.

Several other analysts have also weighed in on the company. Texas Capital raised United States Antimony to a "strong-buy" rating in a report on Wednesday, October 7th. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of United States Antimony in a research note on Monday, September 14th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $8.75.

United States Antimony Trading Down 6.1%

UAMY stock opened at $2.93 on Friday. The firm has a 50 day moving average of $3.81 and a 200-day moving average of $6.93. The company has a market cap of $438.68 million, a price-to-earnings ratio of -22.55 and a beta of 0.49. United States Antimony has a 12-month low of $2.53 and a 12-month high of $12.64.

United States Antimony (NYSE:UAMY - Get Free Report) last released its quarterly earnings results on Thursday, November 12th. The company reported ($0.06) earnings per share for the quarter. United States Antimony had a negative return on equity of 5.29% and a negative net margin of 44.60%. The firm had revenue of $10.13 million during the quarter. Sell-side analysts forecast that United States Antimony will post -0.01 earnings per share for the current fiscal year.

Insider Activity at United States Antimony

In related news, Director Joseph Carrabba acquired 21,300 shares of the firm's stock in a transaction that occurred on Tuesday, September 1st. The shares were acquired at an average price of $4.72 per share, with a total value of $100,536.00. Following the completion of the purchase, the director directly owned 198,401 shares in the company, valued at approximately $936,452.72. The trade was a 12.03% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Lloyd EVP, Chief Mining Officer, & Director acquired 20,000 shares of the company's stock in a transaction that occurred on Tuesday, September 1st. The shares were bought at an average price of $4.63 per share, with a total value of $92,600.00. Following the transaction, the executive vice president owned 932,881 shares in the company, valued at $4,319,239.03. This represents a 2.19% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have purchased a total of 62,700 shares of company stock valued at $298,592 over the last quarter. Insiders own 5.50% of the company's stock.

Institutional Investors Weigh In On United States Antimony

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Global Retirement Partners LLC increased its position in shares of United States Antimony by 209.7% in the third quarter. Global Retirement Partners LLC now owns 58,976 shares of the company's stock worth $246,000 after acquiring an additional 39,936 shares in the last quarter. Fifth Third Bancorp boosted its position in United States Antimony by 23.8% during the 3rd quarter. Fifth Third Bancorp now owns 494,996 shares of the company's stock worth $2,064,000 after purchasing an additional 95,216 shares during the period. Inscription Capital LLC purchased a new stake in United States Antimony during the 3rd quarter worth $47,000. Pilgrim Partners Asia Pte Ltd boosted its position in United States Antimony by 66.2% during the 3rd quarter. Pilgrim Partners Asia Pte Ltd now owns 26,600 shares of the company's stock worth $111,000 after purchasing an additional 10,600 shares during the period. Finally, Axxcess Wealth Management LLC acquired a new stake in United States Antimony in the 3rd quarter valued at $44,000. 9.49% of the stock is currently owned by hedge funds and other institutional investors.

About United States Antimony

United States Antimony Corporation mines, processes and sells antimony and related products. Its offerings include antimony oxide, antimony metal and sodium antimonate, materials used in a range of industrial applications. The company also produces zeolite through its Bear River Zeolite operations in Idaho. Zeolite products are used in applications such as water treatment, agriculture and odor control. Founded in 1968, United States Antimony has processing operations in Montana and Mexico, as well as zeolite operations in Idaho.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.